ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

6 links0 made here, not in the record13 judgments2 judges (the rules as one: Rule based)1 record change seen
Claude Opus 5.5Rule basedRecord updated on ClinicalTrials.gov
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT03425292A Longitudinal Assessmentof Tumor Evolution inPatients With Brain CancerSaint John's Cancer InstitutePhase 1 · completedRECORDThe record itselfVersions seen nightly since Sep 25, 2…›Nov 8 · ClinicalTrials.gov record · MeSH filing re-derivedMeSH filing re-derivedDRUGSTemozolomideIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · ComparatorNov 18 · Rule based · TestedComparatorNivolumabIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedIpilimumabIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedBevacizumabIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedLomustineIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedINT010235Entry “Nivolumab monotherapy”, read b…›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTested

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Temozolomide

From the registry record3 judgments on this link
Role in the study, from the registry to what was judged
RegistryEntry “Temozolomide”the record gives no role
→judged→changed→changed
How the 3 judgments split33%of judgments with a known value say Comparator
Comparator · 1
Tested · 2

All judgments on this study

WhenLinkJudgeDecisionState
Nov 2TemozolomideClaude Opus 5.5TestedCurrent
Nov 2NivolumabClaude Opus 5.5TestedCurrent
Nov 2IpilimumabClaude Opus 5.5TestedCurrent
Nov 2BevacizumabClaude Opus 5.5TestedCurrent
Nov 2LomustineClaude Opus 5.5TestedCurrent
Nov 2INT010235Claude Opus 5.5TestedCurrent
Nov 8The record itselfClinicalTrials.gov recordMeSH filing re-derivedRecord change
Nov 18TemozolomideRule based · role ruleComparatorCurrent
Nov 18TemozolomideRule based · role ruleTestedAgrees
Nov 18NivolumabRule based · role ruleTestedAgrees
Nov 18IpilimumabRule based · role ruleTestedAgrees
Nov 18BevacizumabRule based · role ruleTestedAgrees
Nov 18LomustineRule based · role ruleTestedAgrees
Nov 18INT010235Rule based · role ruleTestedAgrees

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.